Stephens Consulting, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stephens Consulting, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,735
-54.7%
5000.0%0.00%
-60.0%
Q2 2023$12,655
-21.4%
5000.0%0.01%
-50.0%
Q1 2023$16,105
+74.5%
5000.0%0.01%
+66.7%
Q4 2022$9,230
-31.6%
5000.0%0.01%
-50.0%
Q3 2022$13,500
+95.4%
5000.0%0.01%
+100.0%
Q2 2022$6,910
-29.1%
5000.0%0.01%
-25.0%
Q1 2022$9,750
+19.5%
5000.0%0.01%
+14.3%
Q4 2021$8,1605000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders